PortfoliosLab logo

Aptevo Therapeutics Inc. (APVO)

Equity · Currency in USD · Last updated Mar 18, 2023

Share Price Chart

Loading data...


The chart shows the growth of $10,000 invested in Aptevo Therapeutics Inc. in Oct 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $158 for a total return of roughly -98.42%. All prices are adjusted for splits and dividends.

APVO (Aptevo Therapeutics Inc.)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with APVO

Aptevo Therapeutics Inc.


Aptevo Therapeutics Inc. had a return of -23.71% year-to-date (YTD) and -62.66% in the last 12 months. Over the past 10 years, Aptevo Therapeutics Inc. had an annualized return of -46.42%, while the S&P 500 had an annualized return of 9.33%, indicating that Aptevo Therapeutics Inc. did not perform as well as the benchmark.

1 month-13.66%-5.31%
6 months-52.67%0.39%
1 year-62.66%-10.12%
5 years (annualized)-46.80%7.32%
10 years (annualized)-46.42%9.33%

Monthly Returns Heatmap


Sharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Aptevo Therapeutics Inc. Sharpe ratio is -0.73. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.

APVO (Aptevo Therapeutics Inc.)
Benchmark (^GSPC)

Dividend History

Aptevo Therapeutics Inc. doesn't pay dividends

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.

APVO (Aptevo Therapeutics Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below shows the maximum drawdowns of the Aptevo Therapeutics Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Aptevo Therapeutics Inc. is 98.42%, recorded on Mar 17, 2023. The portfolio has not recovered from it yet.



To Bottom


To Recover



-98.42%Jul 22, 20161675Mar 17, 2023

Volatility Chart

Current Aptevo Therapeutics Inc. volatility is 39.38%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.

APVO (Aptevo Therapeutics Inc.)
Benchmark (^GSPC)